[1]桑腮芳.胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果[J].医学信息,2024,37(02):149-152.[doi:10.3969/j.issn.1006-1959.2024.02.031]
　SANG Sai-fang.Clinical Effect of Gastric Mucosal Protective Agent Combined with Hydrogen Pump Inhibitors in the Treatment of Peptic Ulcer Bleeding[J].Journal of Medical Information,2024,37(02):149-152.[doi:10.3969/j.issn.1006-1959.2024.02.031]
点击复制

胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年02期
页码:
149-152
栏目:
论著
出版日期:
2024-01-15

文章信息/Info

Title:
Clinical Effect of Gastric Mucosal Protective Agent Combined with Hydrogen Pump Inhibitors in the Treatment of Peptic Ulcer Bleeding
文章编号:
1006-1959（2024）02-0149-04
作者:
桑腮芳
（黄家驷医院/玉山县人民医院消化内科，江西 玉山 334700）
Author(s):
SANG Sai-fang
(Department of Gastroenterology,Huang Jiasi Hospital/Yushan County People’s Hospital,Yushan 334700,Jiangxi,China)
关键词:
胃黏膜保护剂; 质子泵抑制剂; 消化性溃疡; 出血
Keywords:
Gastric mucosal protective agent; Hydrogen pump inhibitors; Peptic ulcer; Bleeding
分类号:
R969.4
DOI:
10.3969/j.issn.1006-1959.2024.02.031
文献标志码:
A
摘要:
目的 观察胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果。方法 选取2019年5月-2022年5月在我院诊治的60例消化性溃疡伴出血患者为研究对象，采用随机数字表法分为对照组（n=30）和观察组（n=30），对照组采用质子泵抑制剂治疗，观察组在对照组基础上联合胃黏膜保护剂。比较两组临床疗效、止血时间、溃疡愈合时间、腹痛消失时间、临床症状评分（腹痛、腹胀、反酸、嗳气）、炎症因子水平[C反应蛋白（CRP）、白细胞介素-6（IL-6）]以及不良反应发生率。结果 观察组治疗总有效率为93.33%，高于对照组的80.00%（P＜0.05）；观察组止血时间、溃疡愈合时间、腹痛消失时间均短于对照组（P＜0.05）；观察组腹痛、腹胀、反酸、嗳气评分均低于对照组（P＜0.05）；两组治疗后CRP、IL-6水平均低于治疗前，且观察组低于对照组（P＜0.05）；观察组不良反应发生率（6.67%）低于对照组（16.67%）（P＜0.05）。结论 消化性溃疡伴出血采用胃黏膜保护剂与质子泵抑制剂联合治疗可提高总有效率，缩短临床症状消失时间，减少中医证候，降低炎性因子水平，且可减少不良反应，是一种安全、有效的治疗方案，值得临床应用。
Abstract:
bjective To observe the clinical efficacy of gastric mucosal protective agent combined with hydrogen pump inhibitors in the treatment of peptic ulcer bleeding.Methods From May 2019 to May 2022, 60 patients with peptic ulcer bleeding diagnosed and treated in our hospital were selected as the research objects. They were divided into control group (n=30) and observation group (n=30) by random number table method. The control group was treated with hydrogen pump inhibitors, and the observation group was combined with gastric mucosal protective agent on the basis of the control group. The clinical efficacy, hemostasis time, ulcer healing time, abdominal pain disappearance time, clinical symptom scores (abdominal pain, abdominal distension, acid reflux, belching), inflammatory factor levels [C-reactive protein (CRP), interleukin-6 (IL-6)] and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.33%, which was higher than 80.00% in the control group (P<0.05). The hemostasis time, ulcer healing time and abdominal pain disappearance time in the observation group were shorter than those in the control group (P<0.05). The scores of abdominal pain, abdominal distension, acid reflux and belching in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of CRP and IL-6 in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). The incidence of adverse reactions in the observation group (6.67%) was lower than that in the control group (16.67%) (P<0.05).Conclusion The combined treatment of gastric mucosal protective agent and Proton-pump inhibitor can increase the total effective rate, shorten the time of clinical symptoms disappearing, reduce the TCM syndrome and inflammatory factors in peptic ulcer with bleeding, and can reduce adverse reactions, is a safe and effective treatment, worthy of clinical application.

参考文献/References:

[1]胡明,王钢.胃内pH值与上消化道出血的相关性及药物治疗体会[J].现代消化及介入诊疗,2017,22(6):827-829.[2]刘晓川,王静,郭敏,等.四联疗法后延长质子泵抑制剂和铋剂治疗对胃炎患者幽门螺杆菌根除效果的影响[J].临床和实验医学杂志,2019,18(10):1064-1068.[3]李常娟,张金华,魏俊伟,等.铋剂四联疗法联合双岐三联活菌对Hp感染患者的疗效[J].基因组学与应用生物学,2019,38(4):1939-1943.[4]张丹,闫伟.内镜联合喷洒血凝酶,质子泵抑制剂治疗消化性溃疡出血患者的临床疗效[J].中国药物经济学,2022,17(1):114-116,120.[5]陈小银.不同质子泵抑制剂对Hp阳性消化性溃疡疗效[J].中外医学研究,2021,19(8):17-19.[6]李文博,原瑞芳,马丹.布拉酵母菌联合以质子泵抑制剂为基础的标准三联疗法对幽门螺杆菌感染患儿幽门螺杆菌根除率及血清细胞因子的影响[J].中国药物与临床,2021,21(24):4017-4019.[7]刘鹏,胡阳黔,何旭东,等.序贯与标准的三联疗法对幽门螺杆菌阳性的消化性溃疡治疗效果的分析[J].临床消化病杂志,2017,29（5）:287-290.[8]张猛,孙斌,王亚雷,等.EAS法评估PPI联合黏膜保护剂对ESD术后溃疡愈合的影响[J].安徽医科大学学报,2017,52(8):1214-1218.[10]周磊,范月娟,陈福元.质子泵抑制剂联合康复新液对消化性溃疡患者的炎症因子及免疫能力的调控作用[J].中国老年学,2017,36(17):4262-4264.[11]苟学龙.艽龙胶囊联合PPI四联疗法对幽门螺杆菌性消化性溃疡的临床疗效研究[J].内蒙古中医药,2018,35(17):80.[12]朱友.注射用奥美拉唑联合康复新液治疗消化性溃疡并出血患者的疗效观察[J].中南医学科学杂志,2017,44(6):613-617．[13]罗哲,付山峰,闫志辉,等.消化性溃疡伴出血的特征及危险因素分析[J].胃肠病学和肝病学杂志,2017,20(5):218-220.[14]郝婷婷,马晓鹏,袁东红,等.含铋剂四联疗法在消化性溃疡幽门螺杆菌感染根除中的临床价值[J].河北医药,2017,39(5):713-715．[15]郝金海.不同剂量奥美拉唑联合内镜下止血治疗中低危消化性溃疡出血的效果比较[J].河南医学研究,2019,28(15):2741-2742.[16]郭金蕾.非甾体抗感染药相关消化性溃疡伴出血患者的临床特点[J].深圳中西医结合杂志,2019,30(7):81-83.[17]周艳华,宗晔,张澍田,等.注射用右旋雷贝拉唑钠治疗消化性溃疡合并上消化道出血的疗效和安全性分析[J].临床和实验医学杂志,2020,19(14):1495-1499.[18]梁丽燕,陈健,苏有盛.内镜配合喷洒血凝酶PPI治疗消化性溃疡出血的疗效评价[J].基层医学论坛,2021,25(4):472-474.[19]江明万,于双,王晴雷,等.含铋剂四联疗法治疗消化性溃疡并幽门螺杆菌感染的效果观察[J].中国基层医药,2016,23(15):2297-2300.[20]屈海燕,强文娟,阿英.泮托拉唑联合胃镜喷洒血凝酶治疗消化性溃疡合并出血的效果分析[J].解放军医药杂志,2020,32(5):73-77.

相似文献/References:

[1]冯曲波,颜 婷,伍国林.2014年~2016年我院质子泵抑制剂应用分析[J].医学信息,2018,31(08):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
　FENG Qu-bo,YAN Ting,WU Guo-lin.Application of Proton Pump Inhibitors in our Hospital from 2014 to 2016[J].Journal of Medical Information,2018,31(02):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
[2]毕月玲,潘丽华,闫永悦.2017年第一、二季度我院口服质子泵抑制剂 应用情况分析[J].医学信息,2018,31(10):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
　BI Yue-ling,PAN Li-hua,YAN Yong-yue.Application of Oral Proton Pump Inhibitors in our Hospital in the First,Second Quarter of 2017[J].Journal of Medical Information,2018,31(02):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
[3]何志钧,梁运啸,梁列新.质子泵抑制剂治疗上消化道出血对痛风复发的影响[J].医学信息,2019,32(01):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
　HE Zhi-jun,LIANG Yun-xiao,LIANG Lie-xin.Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout[J].Journal of Medical Information,2019,32(02):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
[4]张金富,周细妹.质子泵抑制剂联合铝镁加混悬液治疗胃内镜黏膜溃疡的临床价值[J].医学信息,2024,37(07):127.[doi:10.3969/j.issn.1006-1959.2024.07.025]
　ZHANG Jin-fu,ZHOU Xi-mei.Clinical Value of Proton Pump Inhibitor Combined with Aluminum Magnesium Suspension in the Treatment of Gastric Endoscopic Mucosal Ulcer[J].Journal of Medical Information,2024,37(02):127.[doi:10.3969/j.issn.1006-1959.2024.07.025]

更新日期/Last Update: 1900-01-01